Sandu Pharmaceuticals

Sandu Pharmaceuticals EBIT per Share

The EBIT per Share of Sandu Pharmaceuticals (524703.BO) as of Oct 31, 2026 is 2.80 INR. In the previous year, EBIT per Share was 2.34 INR — a change of 19.90% (higher).

EBIT per Share

2.80INR

YoY

19.90%

Last updated:

EBIT per Share of Sandu Pharmaceuticals is 2026 2.80 INR. EBIT per Share of Sandu Pharmaceuticals was 2025 2.34 INR. It decreases by 19.90% higher compared to the previous year.

The Sandu Pharmaceuticals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
1.51 INR
Jan 1, 2020
0.93 INR
Jan 1, 2021
1.66 INR
Jan 1, 2022
2.43 INR
Jan 1, 2023
2.38 INR
Jan 1, 2024
2.21 INR
Jan 1, 2025
2.34 INR
Jan 1, 2026
2.80 INR
The Sandu Pharmaceuticals EBIT per Share history
YEAREBIT per ShareYoY
2.80INR+19.90%
2.34INR+5.77%
2.21INR-6.99%
2.38INR-2.03%
2.43INR+46.27%
1.66INR+77.83%
0.93INR-38.09%
1.51INR-21.93%
1.93INR-40.01%
3.22INR+4.62%
3.08INR+76.77%
1.74INR+4.78%
1.66INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sandu Pharmaceuticals Stock analysis

What does Sandu Pharmaceuticals do? Sandu Pharmaceuticals Ltd is a Mumbai-based company operating in the Consumer Staples sector, specifically within the consumer products industry. Listed on September 26, 1994, the firm manufactures and markets Ayurvedic medicines. Its product portfolio spans digestive health, immunity, muscle and bone health, respiratory health, and general wellness. Specific offerings address conditions such as constipation, hyperacidity, asthma, and colds, while also covering female, male, and mother-and-child wellness. The company utilizes in-house know-how from Sandu Brothers Private Limited for production and distributes its goods, including immunity kits and power herbs, through e-commerce marketplaces. Sandu Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sandu Pharmaceuticals stock

EBIT per Share of Sandu Pharmaceuticals is 2.80 INR in 2026.

EBIT per Share of Sandu Pharmaceuticals changed from 2.34 INR to 2.80 INR, representing a 19.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Sandu Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sandu Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sandu Pharmaceuticals